Webinar | August 9, 2017

What’s New on Section 101 Jurisprudence

  • post-grant-review1
  • life-sciences-research
  • patent-litigation

In this webinar, the panel, including Brooks Kuhsman Shareholder David Randall, discussed updates on patent eligible subject matter since the Alice Bank, Enfish, Mayo Collaborative, and Sequenom v. Ariosa line of cases. They covered case law from federal courts, decisions from the PTAB, results of the USPTO’s roundtables last year on Section 101, as well as recent recommendations from trade associations such as IPO and AIPLA on proposals for legislation change. The panel also discussed the effect of current Section 101 jurisprudence on the technology, software, and biotechnology/biologics industries, and whether the laws as applied in the U.S. are consistent with our obligations under certain international treaties.


Releated Webinars